Oracle Health, Cleveland Clinic and Abu Dhabi-based tech holding group G42 are partnering on the development of an artificial-intelligence-based platform for healthcare delivery, which the trio says will enable point-of-care clinical data applications while streamlining life sciences innovation.
The project, part of a nonbinding agreement announced Friday, will be largely built on Oracle tech—specifically, its Oracle Cloud Infrastructure, Oracle AI Data Platform and various Oracle Health applications. Cleveland Clinic will provide clinical know-how, while G42 will contribute its capabilities and knowledge in health data integration, clinical AI models and building AI infrastructure at the sovereign level.
“Aging populations, rising costs and the complexity of care demand a complete reinvention of how healthcare is provided,” Oracle Executive Chairman and Chief Technology Officer Larry Ellison said in the announcement. “Oracle’s AI Data Platform and suite of clinical applications can help us understand disease and population health in ways that fuel scientific breakthroughs, reduce the cost of care delivery and improve patient care. Together with Cleveland Clinic and G42, we will deliver the modern tools providers need to help people live longer, healthier lives.”
The partners said their scalable platform will be designed with global population needs in mind but will initially begin working within the U.S. and the United Arab Emirates to position the countries as “co-leaders in supporting next-generation healthcare solutions.” The announcement did not give a potential timeline for the platform’s development or deployments but stressed that the infrastructure would be “rooted in data privacy.”
Once the platform has been established, the partners envision a scenario where health systems can conduct continuous “nation-scale data analytics,” with clinical takeaways being delivered to practitioners during care encounters. This could include AI-enhanced diagnostics or personalized treatments.
These data could also help identify larger-scale factors contributing to disease within patient populations, they said, or help individual organizations improve their patient and financial outcomes through data-driven analysis and prediction.
The partners added that their platform will more closely integrate clinical care and research by allowing providers to more easily identify and enroll candidates for clinical trials, again at the point of care. On the other end, researchers will be able to directly monitor real-world data to measure the performance of existing or novel therapies, as well as more quickly act upon detrimental effects they spot within the data.
“As a leader in healthcare, it is a moral imperative to create solutions that benefit the health and wellness of people,” Cleveland Clinic President, CEO and Chair Tom Mihaljevic, M.D., said in the announcement. “An AI-enabled model of care could positively impact global health systems—a flagship example of how data-driven, tech-powered healthcare can deliver better outcomes, lower costs, and expand access worldwide.”
There’s precedent for collaboration between Cleveland Clinic and G42, as the organizations had already worked together to establish Cleveland Clinic Abu Dhabi in 2015. The health system has also had a “decades-long partnership” with the UAE, per the announcement.
Oracle Health, which purchased electronic health record vendor Cerner in 2021, has spent the last few years upping its tech capabilities—a clinical AI agent, seamless data exchange and the Oracle Cloud Infrastructure. The tech company said these tools would be at the heart of a next-gen EHR platform it’s releasing this year. At the same time, Cerner’s EHR market share among U.S. hospitals appears to have declined in recent years, according to estimates from KLAS Research.